Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 65Lymphoma, Large B-Cell, Diffuse 48Lymphoma 34Burkitt Lymphoma 28Lymphoma, Follicular 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Lymphoma, Non-Hodgkin 14Neoplasms 13Lymphoma, B-Cell 12Lymphoma, T-Cell, Peripheral 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Hodgkin Disease 9Lymphoma, B-Cell, Marginal Zone 8Leukemia 7Recurrence 6Prostatic Neoplasms, Castration-Resistant 6Multiple Myeloma 6Leukemia, Lymphocytic, Chronic, B-Cell 6Neoplasm Metastasis 5Leukemia, Biphenotypic, Acute 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoproliferative Disorders 4Lymphoma, T-Cell 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Anaplastic 4Immunoblastic Lymphadenopathy 4Ovarian Neoplasms 3Myasthenia Gravis 3Metastatic Castration-resistant Prostate Cancer 3Melanoma 3

Interventions

Transcranial Direct Current Stimulation 2Exercise 2mazdutide 1lime 1fasudil 1enzalutamide 1Time 1Tablets 1Standard of Care 1Referral and Consultation 1Ramipril 1Radiosurgery 1Prednisone 1Population Groups 1Palliative Care 1Organization and Administration 1Modafinil 1Methods 1Metformin 1Mental Status and Dementia Tests 1Memantine 1Low-Level Light Therapy 1Hormones 1Health 1Gonadotropin-Releasing Hormone 1Electroencephalography 1Drug Delivery Systems 1Data Collection 1Anesthesia, General 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Prednisone × 1 year × Clear all
NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Northwestern University

Phase 4 Active not recruiting
100 enrolled
Genitourinary

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡